Affecting approximately 262 million people worldwide, asthma is a chronic condition of the lungs that causes airway inflammation. 1. Typical symptoms include: Breathlessness; Whee ...

'Alarming' figures show thousands more patients have needed emergency care.

After a guideline change recommending allergenic food introduction at age 4 to 6 months, the likelihood for emergency room ...

Estimated annual cost of asthma management totaled $2,181 per SMART-prescribed patient compared with $2,235 with traditional ...

Dryer sheets help reduce static cling while improving the fragrance of clothes. However, some scented dryer sheets have been known to cause everything from skin reactions to migraines.

A mother's health during pregnancy, childbirth and the postpartum period is the foundation of lifelong well-being, directly ...

Researchers and doctors are beginning to modernize asthma treatment using innovative therapies. Asthma is a common, chronic, ...

Omalizumab or dupilumab suggested for adults with moderate-to-severe allergic asthma, history of exacerbations requiring oral corticosteroids ...

Asthma is one of the most prevalent chronic inflammatory respiratory diseases across the globe, with a significant increase in mortality and morbidity in recent years, affecting all age groups ...

In these guidelines, the American Heart Association provides updated guidance for resuscitation of adults and children in cardiac arrest or with a life-threatening condition due to special ...

A new option for hard-to-control asthma: The FDA has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for people with severe asthma. Designed to reduce flare-ups: The injectable ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved depemokimab (Exdensur, GSK plc) as add-on therapy for severe asthma and for chronic rhinosinusitis with nasal polyps (CRSwNP ...